Sandur Manganese & Iron Ores Merger & Restructuring Worth ₹1 Cr

Sandur Manganese & Iron Ores Board Meeting Date

Sandur Manganese & Iron Ores will hold a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window is closed from 1 October 2026 until 48 hours after the meeting.

Sandur Manganese & Iron Ores Capacity Expansion

SMIORE's subsidiary Royal Sandur MedTech leased 6.2 acres at AP MedTech Zone, Visakhapatnam for a medical devices manufacturing unit. This marks the company's entry into the medical devices segment.

Execution

33-year lease tenure

land for medical devices manufacturing unit

6.2 acres

Sandur Manganese & Iron Ores Other Announcement

Sandur Manganese & Iron Ores Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.

Sandur Manganese & Iron Ores Merger & Restructuring Worth ₹1 Cr

The Sandur Manganese & Iron Ores Ltd incorporated a new wholly owned subsidiary, Royal Sandur MedTech Private Limited, for medical devices and consumables manufacturing.

Value

₹1.00 Cr

Sandur Manganese & Iron Ores Merger & Restructuring Worth ₹1 Cr

Sandur Manganese & Iron Ores approved the incorporation of a wholly-owned subsidiary, 'Royal Sandur MedTech Private Limited', with a capital investment of ₹1 Crore.

Value

₹1.00 Cr

Sandur Manganese & Iron Ores Legal & Regulatory

Sandur Manganese & Iron Ores Ltd's subsidiary, Royal Sandur Metals Private Limited, received a customs penalty order of ₹0.12 Crore.

Value

₹0.12 Cr

Quint Digital Merger & Restructuring

Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.

Hexaware Technologies Merger & Restructuring

Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.

Execution

Expected completion by 30 June 2027; agreement date stated as 1 December 2026

Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr

Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.

Value

₹2.75 Cr

Execution

Completion expected by 26 January 2027

TVS Holdings Merger & Restructuring

TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.

Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr

Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.

Value

₹30.00 Cr

Execution

Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals

Fortis Healthcare Merger & Restructuring Worth ₹277 Cr

Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.

Value

₹277.0 Cr